Vivos Therapeutics(VVOS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

VVOS Vivos Therapeutics

Post-Mkt 06-09 18:38:04 EDT

0.7002

-0.1698

-19.52%

盘后0.7024

+0.0022+0.31%

18:24 EDT

High0.9800	Low0.6944	Vol1.30M
Open0.9140	D1 Closing0.8700	Amplitude32.83%
Mkt Cap9.73M	Tradable Cap8.44M	Total Shares13.89M
T/O1.02M	T/O Rate10.82%	Tradable Shares12.05M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"VVOS","market":"US","secType":"STK","nameCN":"Vivos Therapeutics","latestPrice":0.7002,"timestamp":1781035200000,"preClose":0.87,"halted":0,"volume":1303531,"hourTrading":{"tag":"盘后","latestPrice":0.7024,"preClose":0.7002,"latestTime":"18:24 EDT","volume":11776,"amount":8357.1787264,"timestamp":1781043848778,"change":0.0022,"changeRate":0.003142,"amplitude":0.071265},"delay":0,"changeRate":-0.1951724137931034,"floatShares":12046600,"shares":13894600,"eps":-2.120576,"marketStatus":"Post-Mkt","change":-0.1698,"latestTime":"06-09 18:38:04 EDT","open":0.914,"high":0.98,"low":0.6944,"amount":1024272.1646894,"amplitude":0.328276,"askPrice":0.76,"askSize":100,"bidPrice":0.7049,"bidSize":2,"shortable":0,"etf":0,"ttmEps":-2.120576,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1781049600000},"marketStatusCode":4,"adr":0,"listingDate":1607662800000,"exchange":"NASDAQ","adjPreClose":0.87,"preHourTrading":{"tag":"盘前","latestPrice":0.9,"preClose":0.87,"latestTime":"09:28 EDT","volume":87920,"amount":72955.198344,"timestamp":1781011720741,"change":0.03,"changeRate":0.034483,"amplitude":0.177816},"postHourTrading":{"tag":"盘后","latestPrice":0.7024,"preClose":0.7002,"latestTime":"18:24 EDT","volume":11776,"amount":8357.1787264,"timestamp":1781043848778,"change":0.0022,"changeRate":0.003142,"amplitude":0.071265},"volumeRatio":0.087598,"impliedVol":2.594,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/VVOS/tweets","defaultTab":"tweets","newsList":[{"id":"2642435276","title":"Vivos Therapeutics CEO to present at Small Cap Showcase & WTR Insights","url":"https://stock-news.laohu8.com/highlight/detail?id=2642435276","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642435276?lang=en_us&edition=fundamental","pubTime":"2026-06-09 01:39","pubTimestamp":1780940372,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics will attend The Small Cap Showcase & WTR Insights in New York City on June 9, 2026.CEO Kirk Huntsman is scheduled to give a corporate presentation at 11:30 a.m. ET.Management plans one-on-one meetings with pre-qualified investors during the event.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL8ZzNcX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4196","IE00B3QW5Z07.USD","LU0314104364.USD","BK4112","IE00BN0W2W23.USD","LU2210150020.SGD","VVOS","BK4585","SG9999014013.SGD","LU2095319765.USD","NDAQ","IE00BN0W2V16.EUR","IE00BKPKM429.USD","SG9999014039.USD","IE00BN0W2T93.GBP","LU2210149790.SGD","SG9999014005.SGD","IE00BGHQF748.EUR","BK4588","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642891436","title":"Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2642891436","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642891436?lang=en_us&edition=fundamental","pubTime":"2026-06-09 01:39","pubTimestamp":1780940340,"startTime":"0","endTime":"0","summary":"LITTLETON, Colo., June  08, 2026  (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treat","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/08/3308377/0/en/Vivos-Therapeutics-To-Participate-in-the-Small-Cap-Showcase-WTR-Insights-on-June-9-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVOS","BK4196","CARE","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641614762","title":"Sector Update: Healthcare Stocks Higher Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2641614762","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641614762?lang=en_us&edition=fundamental","pubTime":"2026-06-06 03:49","pubTimestamp":1780688942,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose late Friday afternoon with the NYSE Healthcare Index increasing 0.6% and the State Street Health Care Select Sector SPDR ETF  adding 0.7%.The iShares Biotechnology ETF  declined 1.6%.In corporate news, Haemonetics  updated its financial reporting structure and will transition to two segments from three starting in Q1 fiscal 2027. The stock rose 1.8%.BioCardia  received confirmation from the US Food and Drug Administration that its ongoing trial may support a premarket approval of the CardiAMP Cell Therapy System for the treatment of ischemic heart failure with reduced ejection fraction. BioCardia shares climbed 23%.CareCloud  said shareholders approved all proposals put forward at the annual investor meeting on Thursday, including the re-election of Mahmud Haq and Cameron Munter to the board. CareCloud shares fell 1.5%.Vivos Therapeutics  entered a deal with its senior secured lender, Streeterville Capital, to exchange up to $4.5 million of its outstanding debt f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1169589451.USD","VVOS","LU1169590202.USD","IE00B19Z6F94.USD","BCDA","BK4139","HAE","BK4196","HCSG","LU0029874061.USD","XBI","BK4137","BK4167","LU0205193047.USD","IBB","CCLD","IE00B64QTZ34.USD","BK4588","LU0106261612.USD","LU0012050646.USD","XLV","LU0128526141.USD","IE0034390439.USD","IE00BLDYK493.USD","BK4581","LABU","BK4198","LU0205194284.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641435191","title":"Vivos Therapeutics Agrees Debt for Equity Deal With Streeterville Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2641435191","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641435191?lang=en_us&edition=fundamental","pubTime":"2026-06-05 21:03","pubTimestamp":1780664610,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics  entered a deal with its senior, secured lender, Streeterville Capital to exchange up to $4.5 million of its outstanding debt for a combination of perpetual, nonconvertible preferred stock and shares, the company said Friday.The agreement includes commitments by Streeterville to suspend any calls for repayment of its debt and any sales of company securities for 90 and 60 days, respectively, from the date the deal becomes effective, the company said.The conversion of Streeterville's debt into equity is meant to advance shareholders' positions and comply with Nasdaq listing standards, the company said.Shares of the company were up 5.1% in recent premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","EQR","VVOS","BK4215","BK4585","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641484971","title":"Vivos Therapeutics agrees to exchange up to $4.5 million Streeterville debt into preferred, common stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2641484971","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641484971?lang=en_us&edition=fundamental","pubTime":"2026-06-05 20:45","pubTimestamp":1780663522,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics signed a binding deal with Streeterville Capital to swap up to USD 4.5 million of senior secured debt into preferred stock and common shares.Streeterville committed to pause debt repayment demands for 90 days once the exchange takes effect.The lender also agreed to halt sales of company securities for 60 days.The exchange hinges on one or more qualifying equity financings acceptable to Vivos.The transaction targets improved stockholders’ equity to support Nasdaq listing compliance, reduced debt service, stronger cash flow, improved liquidity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDL9btjRc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","BK4196","BK4585","IE00BN0W2W23.USD","NDAQ","SG9999014005.SGD","IE00BN0W2T93.GBP","BK4588","LU2095319765.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014013.SGD","IE00BKPKM429.USD","SG9999014021.USD","LU0314104364.USD","BK4112","IE00BN0W2V16.EUR","VVOS","IE00BGHQF748.EUR","LU2210149790.SGD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641127148","title":"Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of up to $4.5 Million From Streeterville Capital to Support Continued Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2641127148","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641127148?lang=en_us&edition=fundamental","pubTime":"2026-06-05 20:45","pubTimestamp":1780663500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nTUA6JLKCW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641148415","title":"Press Release: Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2641148415","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641148415?lang=en_us&edition=fundamental","pubTime":"2026-06-05 20:45","pubTimestamp":1780663500,"startTime":"0","endTime":"0","summary":"LITTLETON, Colo., June 05, 2026  -- Vivos Therapeutics, Inc.  , a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated chronic health conditions, including obstructive sleep apnea , today announced that it has entered into a binding agreement with its senior, secured lender, Streeterville Capital, LLC  to exchange up to $4.5 million of its outstanding debt into a combination of perpetual, nonconvertible preferred stock and shares of common stock of the Company.In addition, the agreement includes commitments from Streeterville to suspend any calls for repayments of its debt and any sales of Company securities for 90 and 60 days, respectively, from the date the debt-to-equity exchange becomes effective.The debt-to-equity exchange will be supported by, and is contingent on the completion of one or more qualifying equity financings on terms acceptable to the Company. There can be no assurance that any such finan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARE","BK4215","EQR","VVOS","BK4585","BK4211","BK4588","BK4196","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640715982","title":"Vivos Therapeutics Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2640715982","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640715982?lang=en_us&edition=fundamental","pubTime":"2026-06-04 18:02","pubTimestamp":1780567320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VVOS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 04, 2026 06:02 ET (10:02 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637652113","title":"Vivos Therapeutics Earnings Call: Growth Meets Cash Strain","url":"https://stock-news.laohu8.com/highlight/detail?id=2637652113","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637652113?lang=en_us&edition=fundamental","pubTime":"2026-05-22 08:30","pubTimestamp":1779409815,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics, Inc. (($VVOS)) has held its Q1 earnings call. Read on for the main highlights of the call. Vivos Therapeutics’ latest earnings ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vivos-therapeutics-earnings-call-growth-meets-cash-strain?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vivos-therapeutics-earnings-call-growth-meets-cash-strain?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637730658","title":"Vivos Therapeutics reports Q1 EPS (52c), consensus (45c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637730658","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637730658?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:22","pubTimestamp":1779308529,"startTime":"0","endTime":"0","summary":"Reports Q1 revenue $5.14M, consensus $4.35M. Kirk Huntsman, Vivos’ chairman and CEO, stated “Our significant revenue increase year over year and qu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vivos-therapeutics-reports-q1-eps-52c-consensus-45c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vivos-therapeutics-reports-q1-eps-52c-consensus-45c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637878761","title":"Vivos Therapeutics Q1 revenue jumps, driven by SCN acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2637878761","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637878761?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:19","pubTimestamp":1779308399,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics Q1 revenue jumps, driven by SCN acquisitionOverviewU.S. sleep disorder device maker's Q1 revenue rose 70% yr/yr, driven by SCN acquisitionGross profit for Q1 increased 103% yr/yr, w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL1N41X14Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637787518","title":"Vivos Therapeutics Q1 EPS $(0.52) Misses $(0.45) Estimate, Sales $5.141M Beat $4.225M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2637787518","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637787518?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:18","pubTimestamp":1779308327,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.45) by 15.56 percent. This is a 15.56 percent decrease over losses of $(0.45) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52704785/vivos-therapeutics-q1-eps-0-52-misses-0-45-estimate-sales-5-141m-beat-4-225m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Vivos Therapeutics Q1 EPS $(0.52) Misses $(0.45) Estimate, Sales $5.141M Beat $4.225M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637878150","title":"Vivos Therapeutics Q1 FY26 net loss more than doubles to $7.8 million; revenue rises 70% to $5.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2637878150","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637878150?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:11","pubTimestamp":1779307862,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics posted a net loss of $7.75 million, more than doubled from a year earlier, as revenue climbed 70% to $5.14 million.Gross margin widened to 60% from 50% a year earlier, while operating expenses jumped 78% to $9.67 million.Cash and cash equivalents totaled $2.11 million at March 31, with stockholders’ equity at a deficit of $1.14 million.Oral appliance sales volumes rose 42% to 5,304, while revenue from oral appliance sales to legacy VIP dentist customers fell to $1.44 million.CEO Kirk Huntsman said the June 2025 acquisition of The Sleep Center of Nevada is driving patient volume and top-line growth, with a “very significant” reduction in customer acquisition costs and efforts underway to improve insurance reimbursement and restructure debt.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL3kfqSk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4112","SG9999014013.SGD","IE00BN0W2T93.GBP","SG9999014021.USD","BK4585","SG9999014005.SGD","IE00BN0W2V16.EUR","NDAQ","LU2210150020.SGD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","LU0314104364.USD","VVOS","IE00B3QW5Z07.USD","SG9999014039.USD","BK4196","LU2210149790.SGD","BK4588","LU2095319765.USD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637121878","title":"BRIEF-Vivos Therapeutics Q1 Net Income USD -7.751 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2637121878","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637121878?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:10","pubTimestamp":1779307845,"startTime":"0","endTime":"0","summary":"BRIEF-Vivos Therapeutics Q1 Net Income USD -7.751 Million\n\n\nMay 20 (Reuters) - Vivos Therapeutics Q1 gross profit USD 3.059 million.\n\nQ1 operating income USD -6.615 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nPLX05A3B2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVOS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637878988","title":"Vivos Therapeutics Q1 Gross Profit USD 3.059 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2637878988","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637878988?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:10","pubTimestamp":1779307800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nPLX05A3B2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VVOS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637878641","title":"Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2637878641","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637878641?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:10","pubTimestamp":1779307800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUA6HLVVC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VVOS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635552056","title":"Vivos Therapeutics Delays Quarterly Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635552056","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635552056?lang=en_us&edition=fundamental","pubTime":"2026-05-16 07:35","pubTimestamp":1778888133,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics ( ($VVOS) ) has released a notification of late filing. Vivos Therapeutics, Inc. has filed a Form 12b-25 to notify investors of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vivos-therapeutics-delays-quarterly-filing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vivos-therapeutics-delays-quarterly-filing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VVOS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635037992","title":"Vivos Therapeutics delays Q1 10-Q filing, seeks SEC extension","url":"https://stock-news.laohu8.com/highlight/detail?id=2635037992","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635037992?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:08","pubTimestamp":1778875713,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics filed a Form 12b-25 to delay its quarterly report for period ended March 31, 2026.Filing cited need for more time to complete review of interim financial statements for Sleep Center of Nevada, acquired in 2025, before consolidating results into company unaudited financials.Company expects to file Form 10-Q within five-calendar-day extension under SEC Rule 12b-25.Revenue seen up about 70% year over year, gross profit up about 100%, driven by added patient product and service sales from SCN operations.Sales, general, and administrative expenses expected to rise about 70%, with net loss projected to widen versus prior-year quarter.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivos Therapeutics Inc. published the orig","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL1THF2C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVOS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634258636","title":"Vivos Therapeutics Inc  expected to post a loss of 45 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634258636","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634258636?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:58","pubTimestamp":1778533088,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics Inc  expected to post a loss of45cents a share - Earnings Preview Vivos Therapeutics Inc VVOS.OQ VVOS.O is expected to  show a rise in quarterly revenue when it reports  results on ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL8N41O2K7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629075564","title":"Vivos Therapeutics Faces Nasdaq Listing Compliance Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2629075564","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629075564?lang=en_us&edition=fundamental","pubTime":"2026-04-23 05:03","pubTimestamp":1776891811,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics ( ($VVOS) ) has provided an update. On April 17, 2026, Vivos Therapeutics, Inc. disclosed that Nasdaq had notified the company i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vivos-therapeutics-faces-nasdaq-listing-compliance-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vivos-therapeutics-faces-nasdaq-listing-compliance-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","VVOS","NQmain"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vivos.com","stockEarnings":[{"period":"1week","weight":0.2701},{"period":"1month","weight":0.3087},{"period":"3month","weight":-0.3532},{"period":"6month","weight":-0.6027},{"period":"1year","weight":-0.6099},{"period":"ytd","weight":-0.5714}],"compareEarnings":[{"period":"1week","weight":-0.0255},{"period":"1month","weight":0.0022},{"period":"3month","weight":0.0916},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.2338},{"period":"ytd","weight":0.084}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton, Colorado.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.205284},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.068873},{"month":3,"riseRate":0,"avgChangeRate":-0.209794},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.183475},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.065034},{"month":6,"riseRate":0.666667,"avgChangeRate":0.08381},{"month":7,"riseRate":0.4,"avgChangeRate":-0.104292},{"month":8,"riseRate":0.6,"avgChangeRate":0.170604},{"month":9,"riseRate":0,"avgChangeRate":-0.252021},{"month":10,"riseRate":0.2,"avgChangeRate":-0.105489},{"month":11,"riseRate":0.4,"avgChangeRate":1.251693},{"month":12,"riseRate":0.2,"avgChangeRate":-0.12992}],"exchange":"NASDAQ","name":"Vivos Therapeutics","nameEN":"Vivos Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vivos Therapeutics(VVOS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Vivos Therapeutics(VVOS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Vivos Therapeutics,VVOS,Vivos Therapeutics股票,Vivos Therapeutics股票老虎,Vivos Therapeutics股票老虎国际,Vivos Therapeutics行情,Vivos Therapeutics股票行情,Vivos Therapeutics股价,Vivos Therapeutics股市,Vivos Therapeutics股票价格,Vivos Therapeutics股票交易,Vivos Therapeutics股票购买,Vivos Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vivos Therapeutics(VVOS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Vivos Therapeutics(VVOS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction